森朗生物

森朗CAR-T

先进技术来源
Technology Leader
权威临床队伍
Free Technology Service
患者权益保障

CAR-T技术治疗B细胞恶性肿瘤的临床研

河北医科大学第二医院与河北森朗生物科技有限公司联合开展以CD19作为治疗靶点的CAR-T细胞治疗难治性或复发性的CD19阳性的血液恶性肿瘤（主要包括急性淋巴细胞白血病和B细胞淋巴瘤）的临床研究。

科研技术

The first multiple myeloma patient was treated by Senlang CAR-T in Fourth Hospital of Hebei Medical

Clinical Study of CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

人才招聘

Medical commissioner

Project commissioner

Laboratory technician